Literature DB >> 34962359

Conflicting reports of anti-cytosolic 5'-nucleotidase 1A autoantibodies in juvenile dermatomyositis: comment on the article by Rietveld et al.

Andrew L Mammen1, Iago Pinal-Fernandez1, Lisa G Rider2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34962359      PMCID： PMC9050856          DOI： 10.1002/art.42059

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  5 in total

1.  Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility.

Authors:  Steven A Greenberg
Journal:  Muscle Nerve       Date:  2014-10       Impact factor: 3.217

2.  Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.

Authors:  Richard M Yeker; Iago Pinal-Fernandez; Lisa G Rider; Andrew L Mammen; Takayuki Kishi; Katherine Pak; Ira N Targoff; Frederick W Miller
Journal:  Ann Rheum Dis       Date:  2018-01-23       Impact factor: 19.103

3.  Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.

Authors:  Yoshinao Muro; Hirotaka Nakanishi; Masahisa Katsuno; Michihiro Kono; Masashi Akiyama
Journal:  Clin Chim Acta       Date:  2017-07-04       Impact factor: 3.786

4.  Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.

Authors:  Adam Amlani; May Y Choi; Mark Tarnopolsky; Lauren Brady; Ann E Clarke; Ignacio Garcia-De La Torre; Michael Mahler; Heinrike Schmeling; Claire E Barber; Michelle Jung; Marvin J Fritzler
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

5.  Anti-Cytosolic 5'-Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis.

Authors:  Anke Rietveld; Judith Wienke; Eline Visser; Wilma Vree Egberts; Wolfgang Schlumberger; Baziel van Engelen; Annet van Royen-Kerkhof; Hui Lu; Lucy Wedderburn; Christiaan Saris; Sarah Tansley; Ger Pruijn
Journal:  Arthritis Rheumatol       Date:  2021-05-18       Impact factor: 10.995
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.